Neuromuscular electrical stimulation and the treatment of lower urinary tract dysfunction in multiple sclerosis - A double blind, placebo controlled, randomised clinical trial

Neurourology and Urodynamics

Volumn 27, Issue 3, 2008, Pages 231-237

  McClurg, D ^a,c   Ashe, R G ^b   Lowe Strong, A S ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b ANTRIM AREA HOSPITAL   (United Kingdom)

^c BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Bladder diary; Incontinence; Neurogenic; Pad test; Prospective; Uroflowmetry

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROMYOGRAM; FEEDBACK SYSTEM; FEMALE; HUMAN; INTERMETHOD COMPARISON; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROMUSCULAR ELECTRICAL STIMULATION; PELVIC FLOOR MUSCLE TRAINING; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; URINE INCONTINENCE;

BIOFEEDBACK (PSYCHOLOGY); DOUBLE-BLIND METHOD; ELECTRIC STIMULATION THERAPY; ELECTROMYOGRAPHY; FEMALE; HUMANS; INCONTINENCE PADS; MALE; MULTIPLE SCLEROSIS; MUSCLE STRENGTH; PELVIC FLOOR; PHYSICAL THERAPY MODALITIES; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; URINARY INCONTINENCE; URODYNAMICS;

EID: 40849120136     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20486     Document Type: Article

References (47)

1. Kalsi V, Fowler CJ. Therapy Insight: Bladder dysfunction associated with multiple sclerosis. Nat Clin Pract Urol 2005;2:492-501.
2. Norvedt M, Frugaard J, Mohn J, et al. Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Mult Scler 2007;13:106-12.
3. DasGupta R, Fowler C. Bladder Bowel and sexual dysfunction in multiple sclerosis: Management strategies. Drugs 2003;63:153-66.
4. Madersbacher J, Wyndaele JJ, Iagawa Y, et al. A conservative management in neuropathic urinary incontinence. In: P, Abrams S, Khoury A, Wein editors. Incontinence Plymouth: Health Publication Lts; 2002. pp 697-75.
5. Amarenco G, Ismael SS, Even-Schneider A, et al. Urodynamic effects of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol 2003;169:2210-5.
6. O'Leary ML, Smith CP, Erickson J, et al. Botulinum toxin urethral sphincter injection to restore bladder emptying in a woman with multiple sclerosis. Int J MS Care 2002;4:2.
7. Schulte-Baukioh H, Schobert J, Stoize T, et al. Efficacy of botulinum - A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: An objective and subjective analysis. Neurourol Urodyn 2006;25:110-5.
8. Bø K. Physiotherapeutic techniques. In: MacLean A, Cardozo L, editors. Incontinence in women. London: RCOG; 2002. pp 256-72.
9. Vahtera T, Haaranen M, Viramo-Koskela AL, et al. Pelvic floor rehabilitation is effective in patients with multiple sclerosis. Clin Rehabil 1997;11:211-9.
10. McClurg D, Ashe RG, Marshall K, et al. Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: A Randomised Pilot Study. Neurourol Urodyn 2006;25:337-48.
11. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
12. Lose G, Fantl JA, Victor A, et al. Outcome measures for research in adult women with symptoms of lower urinary tract dysfunction. Neurourol Urodyn 1998;17:255-62.
13. StÖhrer M, Goepel M, Kondo A, et al. The standardisation of terminology in neurogenic lower urinary tract dysfunction. Neurourol Urodyn 1999;18:139-58.
14. StÖhrer M, Castro-Diaz E, Chartier-Kastler G, et al. Guidelines on neurogenic lower urinary tract dysfunction. Eur Assoc Urol 2003; 1-40.
15. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn 2002;21:167-78.
16. Laycock J, Vodusek D. Electrical stimulation. In: Laycock J, Haslam J, editors. Therapeutic management of incontinence and pelvic pain. London: Springer-Verlag; 2002. pp 85-8.
17. Laycock J, Jerwood D. Pelvic floor assessment; the PERFECT scheme. Physiotherapy 2001;87:632-42.
18. Armstrong C. Development of an optimised electrical stimulation regime for strengthening the hand muscles. PhD thesis. University of Manchester, 1998.
19. Jeyaseelan SM, Haslam EJ, Winstanley J, et al. An evaluation of a new pattern of electrical stimulation as a treatment of urinary incontinence: A randomized, double-blind, controlled trial. Clin Rehabil 2000;14:631-40.
20. Fried GW, Goetz G, Potts-Nulty S, et al. A behavioral approach to the treatment of urinary incontinence in a disabled population. Arch Phys Med Rehab 1995;76:1120-24.
21. Millard RJ, Oldenburg BF. The symptomatic urodynamic and psychodynamic results of bladder re-education programs. J Urol 1983;130:715-9.
22. Burgio KL, Whitehead WE, Engel BT. Urinary incontinence in the elderly: Bladder/sphincter biofeedback and toileting skills training. Ann Intern Med 1985;103:507-15.
23. Nakamura M, Sakurai T, Sugao H, et al. Maximal electrical stimulation for urge incontinence. Urol Int 1987;42:285.
24. Betts CD, D'Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993;56:245-50.
25. De Ridder D, Vermeulen C, De Smet E, et al. Clinical assessment of pelvic floor dysfunction in multiple sclerosis: Urodynamic and neurological correlates. Neurourol Urodyn 1998;17:537-42.
26. De Ridder D, Vermeulen C, Ketelaer P, et al. Pelvic floor rehabilitation in multiple sclerosis. Acta Neurologica Belgica 1999;99:61-4.
27. Nortvedt MW, Riise T, Myhr KM, et al. Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult Scler 2001;7:231-5.
28. Kesselring J, Beer S. Symptomatic therapy and neurorehabilitation in multiple sclerosis. Lancet Neurol 2005;4:643-52.
29. Patwardhan MB, Matchar DB, Samsa GP, et al. Cost of multiple sclerosis by level of disability: A review of the literature. Mult Scler 2005;11:232-9.
30. Koch T, Kelly S. Identifying strategies for managing urinary incontinence with women who have multiple sclerosis. J Clin Nurs 1999;8:550-5.
31. Rockwood K, et al. A brief clinical instrument to classify frailty in elderly people. Lancet 1999;353:205-6.
32. Thorm DH, et al. Medically recognised urinary incontinence and risks of hospitalization, nursing home admission and mortality. Age Ageing 1997;26:367-74.
33. Stevenson B, et al. Falls risk factors in an acute-care setting: A retrospective study. Can J Nurs Res 1998;30:97-111.
34. Brown JS, Vittinghoff E, Wyman JF, et al. Urinary incontinence: Does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc 2000;48:721-5.
35. Cardozo L, Coyne K, Versi E. Validation of the Urgency Perception Scale. Br J Urol 2005;95:591-6.
36. Siltberg H, Larsson G, Victor A. Pad weighing tests: The best way to quantify urine loss in patients with incontinence. Acta Obst Gynecol Scand Suppl 1997;166:28-32.
37. Schäfer W, Abrams P, Liao L, et al. International Continence Society. Good urodynamic practices: Uroflowmetry, filling cystometry, and pressure flow studies. Neurourol Urodyn 2002;21:261-74.
38. Porru D, Scarpa RM, Prezioso D, et al. HOUSE Study Group Home and office uroflowmetry for evaluation of LUTS from benign prostatic enlargement. Prostate Cancer Prostatic Dis 2005;8:45-9.
39. Goode PS, Locher JL, Bryant RL, et al. Measurement of post-void residual urine with portable transabdominal bladder ultrasound scanner and urethral catheterisation. Internat Urogynecol J 2000;11:296-300.
40. Bø K, Sherburn M. Evaluation of female pelvic floor muscle function and strength. Phys Ther 2005;85:269-82.
41. Gunnarsson M, Teleman P, Mattiasson A, et al. Effects of pelvic floor exercises in middle aged women with a history of naïve urinary incontinence. Euro Urol 2002;41:556-61.
42. Shumaker SA, Wyman JF, Uebersax JS, et al. Health-related quality of life measures for women with urinary incontinence: The Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res 1994;3:291-306.
43. Cockett AT, Barry MJ, Holdgrewe HL, et al. Indications for treatment of benign prostatic hyperplasia. The American Urological Association Study. Cancer 1991;70:280-3.
44. Barry MJ, Fowler JF, O'Leary MP, et al. The American Urological Association Symptom Index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148:1549-57.
45. Lukacz ES, Lawrence JM, Burchette RJ, et al. The use of Visual Analogue Scale in urogynecologic research: A psychometric evaluation. Am J Obstet Gynecol 2004;191:165-70.
46. Hobart J, Lamping D, Fitzpatrick R, et al. The Multiple Sclerosis Impact Scale (MSIS-29). A new patient-based outcome measure. Brain 2001;124:962-73.
47. Mahoney FI, Barthel DW. Functional evaluation: The Barthel index. Maryland State Med J 1965;14:61-5.